№ lp_1_2_19151
File format: docx
Character count: 2090
File size: 27 KB
Note:
Year
Subject:
Cancer prevention, Chemoprevention studies
Document type:
Submission checklist
Organization / institution:
Division of Cancer Prevention (DCP)
Target audience:
Researchers, Medical professionals
Context:
Submission checklist for revisions or amendments to protocols related to DCP chemoprevention studies, including requirements for documentation and contact information for assistance.
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2021
Region / City:
United States
Subject:
Chemoprevention, Clinical Trials
Document Type:
Protocol Template
Author:
National Cancer Institute (NCI), Division of Cancer Prevention (DCP)
Target Audience:
Researchers, Principal Investigators, Academic Organizations, Clinical Trial Administrators
Period of Validity:
Ongoing
Approval Date:
Not specified
Amendment Date:
Not specified
Protocol Version:
1.0
Date of Last Update:
Not specified
Note:
Year
Contextual Description:
Proposal checklist and document guidance for administrators and principal investigators to ensure submission readiness in UFIRST for departmental, college, and DSP review.
Year:
July 2022
Note:
Region / City
Document Type:
Validation Checklist
Contextual description:
A validation checklist for medicinal product applications within the Decentralized Procedure (DCP) process.
Year:
2021
Region / City:
United States
Subject:
Chemoprevention, Clinical Trials
Document Type:
Protocol Template
Author:
National Cancer Institute (NCI), Division of Cancer Prevention (DCP)
Target Audience:
Researchers, Principal Investigators, Academic Organizations, Clinical Trial Administrators
Period of Validity:
Ongoing
Approval Date:
Not specified
Amendment Date:
Not specified
Protocol Version:
1.0
Date of Last Update:
Not specified
Year:
2022
Region / city:
Rawalpindi
Subject:
Clinical Pathology, Medical Education
Document Type:
Program Guide
Organization / institution:
Rawalpindi Medical University & Allied Hospitals
Author:
Prof. Dr. Wafa Omer
Target audience:
Medical students, faculty, healthcare professionals
Duration:
2 years
Approval Date:
2022
Date of changes:
N/A
Year:
2018
Region / City:
[Not specified]
Subject:
ICT Integration in Education
Document Type:
Monitoring Report
Institution:
[Not specified]
Author:
[Not specified]
Target Audience:
Educational institutions and teachers
Period of Validity:
[Not specified]
Approval Date:
[Not specified]
Date of Changes:
[Not specified]
Year:
2012
Author:
Chase JohnsonCamargo
Document Type:
Reflective Essay
Field of Study:
Business / Education
Institution:
Not specified
Audience:
Academic / Personal Reflection
Date Completed:
November 5th, 2012
Collaborators:
Lissy, Edgar
Format:
Written essay with supporting PowerPoint presentation
Year:
2025
Region:
North Santiam Watershed, Detroit Lake Area, USA
Subject:
Drought Monitoring and Hydrologic Conditions
Document Type:
Monitoring Report
Agency:
National Oceanic and Atmospheric Administration (NOAA)
Author:
NSW Drought Monitoring Team
Monitoring Period:
April 1, 2025
Indicators:
Climate, Hydrology, Environmental, Socioeconomic
Forecast:
One-month and three-month temperature and precipitation outlooks
Reservoir Data:
Detroit Lake Inflow and Boat Ramp Service Levels
Drought Stage:
Stage 0–2 depending on indicator
Year:
2023
Region / city:
UK
Theme:
Oncology, Lung Cancer, Treatment Guidelines
Document type:
Clinical guidelines
Organization / institution:
NICE
Author:
NICE
Target audience:
Healthcare professionals
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Contextual description:
Detailed clinical guidelines outlining the recommended systemic treatments for advanced non-small-cell lung cancer based on disease progression and previous therapies.
Year:
2023
Region / City:
United States
Subject:
Cancer Care Delivery, Oncology Research
Document Type:
Submission Worksheet
Organization / Institution:
National Cancer Institute (NCI)
Author:
NCI Protocol Information Office
Target Audience:
Researchers, Investigators, Study Coordinators
Period of Validity:
Ongoing
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2023
Region / City:
United Kingdom
Theme:
Colorectal Cancer Referral Guidelines
Document Type:
Medical Guidelines
Organization:
National Health Service (NHS)
Author:
National Institute for Health and Care Excellence (NICE), British Society of Gastroenterology (BSG), Association of Coloproctology of Great Britain and Ireland (ACPGBI)
Target Audience:
Healthcare professionals in primary and secondary care
Effective Period:
From August 2023
Date of Approval:
August 2023
Date of Amendments:
None mentioned
Year:
2025
Region / City:
North West NHS GMS region
Topic:
ctDNA testing for NSCLC and breast cancer
Document Type:
Notification
Organization:
NHS England
Author:
Genomics Unit
Target Audience:
NHS Trusts
Period of Action:
2025/26 financial year
Approval Date:
7 November 2025
Date of Changes:
N/A
Context:
Notification regarding the continuation and expansion of ctDNA testing for lung and breast cancer in the North West NHS region for the 2025/26 financial year.
Service:
Lung Cancer Whole Pathway
Document type:
Commissioning guidance
Health system:
NHS England
Period:
2024/25
Date of review:
April 2026
Scope:
Direct and specialised commissioning
Clinical focus:
Lung cancer
Geographical context:
United Kingdom
Policy context:
NHS Long Term Plan
Related pathway:
National Optimal Lung Cancer Pathway
Commissioning themes:
Early diagnosis, reducing variation, living with cancer
Evidence base:
NICE guidance and national standards
Note:
Year
Theme:
Medical, Oncology
Document Type:
Referral Form
Organization / Institution:
University Hospitals Birmingham
Target Audience:
Healthcare professionals, GPs
Context:
Form for urgent referral of patients suspected of having urological cancers to appropriate medical specialists.
Year:
2024
Region / City:
International
Subject:
Nuclear medicine, breast cancer, estrogen receptor imaging
Document type:
Procedure standard / Practice guideline
Organization:
SNMMI, EANM
Authors:
David Mankoff, Sona Balogova, Lisa Dunnwald, Farrokh Dehdashti, Erik DeVries, Laura Evangelista, Michel Van Krutchen, Sofia Carriho Vaz, Amy Fowler, Hannah Linden, Gary Ulaner
Target audience:
Nuclear medicine practitioners, oncologists
Scope period:
Current clinical practice
Approval date:
2024
Revision cycle:
Every 5 years or sooner if indicated
Description:
Clinical guideline detailing standardized procedures for [18F]FES PET imaging of estrogen receptor expression in breast cancer patients, including methodology, interpretation, and quality assurance for diagnostic nuclear medicine.
Year:
2024
Organization:
Breakthrough Cancer Research
Location:
Ireland
Type of Document:
Scholarship Announcement
Target Audience:
Undergraduate students in Clinical, Biological, Epidemiological, Public Health, or Allied health fields
Application Deadline:
29 February 2024
Interview Period:
April 2024
Scholarship Duration:
June – September 2024
Funding Amount:
€3,000 per scholarship
Eligibility:
Students who have completed the 3rd or 4th year of their degree by June 2024, first or upper second-class honours, non-PhD students
Application Method:
Grant Management System submission
Review Criteria:
Academic qualifications, personal statement, research proposal, alignment with Breakthrough strategy and potential impact on cancer
Confidentiality:
All applications treated confidentially according to terms of reference
Year:
2022
Region / City:
N/A
Topic:
VA Informed Consent Addendum, NCI CIRB, Boilerplate Language Revision
Document Type:
Guidance
Organization / Institution:
Department of Veterans Affairs (VA)
Author:
ORD, Office of Research Oversight (ORO), NCI CIRB
Target Audience:
VA Facilities, Research Community
Effective Period:
N/A
Approval Date:
April 6, 2022
Date of Updates:
May 12, 2022
Contextual description:
Guidance document on revisions to VA boilerplate language for NCI studies overseen by the NCI CIRB, detailing required actions for VA Facilities.
Year:
2017
Region / City:
Georgia
Subject:
Cancer prevention, screening, and healthcare services
Document Type:
Evaluation Plan
Organization:
Georgia Department of Public Health
Author:
Janet Y Shin, Kia Powell-Threets
Target Audience:
Health professionals, stakeholders involved in cancer prevention and treatment
Period of validity:
6/30/2017 – 6/29/2022
Approval Date:
1/31/2018
Amendment Date:
5/15/2018
Year:
2011
Region / City:
United States
Topic:
Prostate Cancer, Disability Benefits
Document Type:
Questionnaire
Author:
REDACTED
Target Audience:
Veterans, Healthcare Providers
Period of Validity:
Not specified
Approval Date:
11/02/2010
Revision Date:
4/1/2011, 4/7/2011
Year:
2025
Region / City:
Netherlands
Subject:
Public Private Partnership, Cancer Research
Document Type:
Consortium Agreement
Organization / Institution:
Dutch Cancer Society (KWF), Health~Holland, KiKa, Oncode Institute
Author:
N/A
Target Audience:
Research Institutions, Industry Partners
Period of Validity:
2025
Approval Date:
N/A
Date of Amendments:
N/A
Context:
Legal agreement between multiple participants in a cancer research project under the Dutch PPP programme for rare cancer therapies.